REGIS HEALTHCARE LIMITED (REG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

REG

REG - REGIS HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.05
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.86

03 Feb
2026

0.120

OPEN

$6.65

1.78%

HIGH

$6.94

653,311

LOW

$6.65

TARGET
$8.20 19.5% upside
Franking for last dividend paid out: 70%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA .
FNARENA'S MARKET CONSENSUS FORECASTS
REG: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 16.3 17.7 xxx
DPS (cps) xxx 16.2 19.7 xxx
EPS Growth xxx N/A 8.9% xxx
DPS Growth xxx 25.5% 21.5% xxx
PE Ratio xxx N/A 37.9 xxx
Dividend Yield xxx N/A 2.9% xxx
Div Pay Ratio(%) xxx 99.8% 111.3% xxx

Dividend yield today if purchased 3 years ago: 9.49%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.42

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/09 - ex-div 9.13c (franking 70%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx16.3
DPS All xxxxxxxxxxxxxxx16.2
Sales/Revenue xxxxxxxxxxxxxxx1,152.8 M
Book Value Per Share xxxxxxxxxxxxxxx-5.6
Net Operating Cash Flow xxxxxxxxxxxxxxx306.1 M
Net Profit Margin xxxxxxxxxxxxxxx4.25 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-
Return on Invested Capital xxxxxxxxxxxxxxx-
Return on Assets xxxxxxxxxxxxxxx2.50 %
Return on Equity xxxxxxxxxxxxxxx-
Return on Total Capital xxxxxxxxxxxxxxx-
Free Cash Flow ex dividends xxxxxxxxxxxxxxx175.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx4 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx445 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx192 M
Price To Book Value xxxxxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx86.5 M
Capex % of Sales xxxxxxxxxxxxxxx7.50 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,011 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx90 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx124 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

23/09/2025

1

Buy

$8.50

23.91%

Regis Healthcare provided a trading update following the recent announcement of government funding changes. The company stated the headline 4.7% AN-ACC funding increase equates to just 2.6% y/y funding rise, well below 5%-plus staff cost growth.

The $6.55/day hotelling supplement boost is more than offset by care funding cuts, the company highlighted.

FY26 underlying EBITDA was guided to $130-135m, missing Ord Minnett's forecast by -7%. The broker cut EBITDA forecasts for FY26-27, driving a cut in target price to $8.50 from $9.00.

Buy maintained.

On the issue of government funding, the broker believes development pipelines will slow and more providers might exit, assuming there are no further funding increases in FY26.

FORECAST
Ord Minnett forecasts a full year FY26 dividend of 18.70 cents and EPS of 18.70 cents.
Ord Minnett forecasts a full year FY27 dividend of 25.30 cents and EPS of 25.30 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

02/02/2026

2

Overweight

$8.30

20.99%

Ahead of the first half results for Regis Healthcare of February 23 Jarden forecasts EBITDA of $65.9m. This would be down -3%  comparatively.

The forecast decline is largely stemming from the cycling of a strong second quarter in FY25 where a "one-off profit" of $5m was recorded stemming from government funding.

The broker considers the ongoing review into the accommodation supplement as a major opportunity for the business in the next six months, with the most likely outcome to be a $10-20 increase per resident per day.

Overweight rating. Target is reduced to $8.30 from $8.40.

FORECAST
Jarden forecasts a full year FY26 dividend of 13.80 cents and EPS of 19.70 cents.
Jarden forecasts a full year FY27 dividend of 18.20 cents and EPS of 26.40 cents.
Access Extra Coverage Research History >

REG STOCK CHART

FNArena News on REG

Latest Aged Care & Seniors News

1
Lifestyle Communities Enjoying Strong Demand

Feb 21 2022 - Small Caps
2
Aged Care Sector: Poised

Mar 16 2021 - Australia
3
Pressure Grows On Estia Health

Dec 10 2019 - Australia
4
Aveo Group Now A Binary Proposition

Jun 26 2019 - Australia
5
Aged Care Moves Into The RC Spotlight

Sep 20 2018 - Australia
6
Regis Healthcare In Strong Shape For FY19

Sep 04 2018 - Australia
7
Gateway Pays Up For Expansion

Mar 20 2018 - Small Caps
8
Challenging FY18 For Japara Healthcare

Dec 20 2017 - Small Caps
9
Estia Health Beset By Uncertainty

Dec 13 2016 - Australia
10
More Certainty Welcomed For Aged Care

Dec 07 2016 - Australia